Stage II Breast Cancer AJCC v6 and v7

specific

Stage II breast cancer is divided into stages IIA and IIB. In stage IIA, (1) no tumor is found in the breast, but cancer is found in the axillary (under the arm) lymph nodes; or (2) the tumor is 2 centimeters or smaller and has spread to the axillary lymph nodes; or (3) the tumor is larger than 2 centimeters but not larger than 5 centimeters and has not spread to the axillary lymph nodes. In stage IIB, the tumor is (1) larger than 2 centimeters but not larger than 5 centimeters and has spread to

74

Centers

115

Active Trials

Cancer Funding

Top Centers for Stage II Breast Cancer AJCC v6 and v7(74)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
70.1
270.1
3
NCI Comprehensive
High-Volume Research Center
70.1
4
NCI Comprehensive
High-Volume Research Center
70.1
5
NCI Clinical
High-Volume Research Center
70.1
6
High-Volume Research Center
70.1
7
High-Volume Research Center
70.1
8
High-Volume Research Center
70.1
9
High-Volume Research Center
70.1
10
High-Volume Research Center
70.1
11
NCI Comprehensive
Active Research Program
59.8
12
NCI Comprehensive
Active Research Program
59.8
13
NCI Comprehensive
Active Research Program
59.8
14
NCI Comprehensive
Active Research Program
59.8
15
NCI Comprehensive
Active Research Program
59.8
16
NCI Comprehensive
Active Research Program
59.8
17
NCI Comprehensive
Active Research Program
59.8
18
NCI Comprehensive
Active Research Program
59.8
19
NCI Comprehensive
Active Research Program
59.8
20
Active Research Program
59.8
21
NCI Comprehensive
Active Research Program
59.8
22
NCI Clinical
Active Research Program
59.8
23
NCI Comprehensive
Active Research Program
59.8
24
NCI Clinical
Active Research Program
59.8
25
NCI Comprehensive
Active Research Program
59.8
2659.8
27
Active Research Program
59.8
28
Active Research Program
59.8
29
Active Research Program
59.8
30
Active Research Program
59.8
31
Active Research Program
59.8
32
Active Research Program
59.8
33
Active Research Program
59.8
34
Active Research Program
59.8
35
NCI Comprehensive
Active Research Program
41.2
36
NCI Comprehensive
Active Research Program
41.2
37
NCI Comprehensive
Active Research Program
41.2
38
NCI Comprehensive
Active Research Program
41.2
39
NCI Comprehensive
Active Research Program
41.2
40
NCI Comprehensive
Active Research Program
41.2
41
NCI Comprehensive
Active Research Program
41.2
42
NCI Comprehensive
Active Research Program
41.2
43
NCI Comprehensive
Active Research Program
41.2
44
NCI Comprehensive
Active Research Program
41.2
45
NCI Comprehensive
Active Research Program
41.2
46
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
41.2
47
NCI Comprehensive
Active Research Program
41.2
48
NCI Comprehensive
Active Research Program
41.2
49
NCI Comprehensive
Active Research Program
41.2
50
NCI Clinical
Active Research Program
41.2
51
NCI Comprehensive
Active Research Program
41.2
52
NCI Comprehensive
Active Research Program
41.2
53
NCI Comprehensive
Active Research Program
41.2
54
NCI Comprehensive
Active Research Program
41.2
55
Active Research Program
41.2
56
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
41.2
57
NCI Comprehensive
Active Research Program
41.2
58
NCI Comprehensive
Active Research Program
41.2
59
NCI Comprehensive
Active Research Program
41.2
60
NCI Comprehensive
Active Research Program
41.2
61
NCI Comprehensive
Active Research Program
41.2
62
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
41.2
63
Active Research Program
41.2
64
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
41.2
65
NCI Comprehensive
Active Research Program
41.2
66
Active Research Program
41.2
67
Active Research Program
41.2
68
Active Research Program
41.2
6941.2
70
Active Research Program
41.2
71
BC CancerVancouver, BC
Active Research Program
41.2
72
NCI Comprehensive
29.1
73
NCI Comprehensive
29.1
74
NCI Comprehensive
29.1

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →